J Korean Neuropsychiatr Assoc.  2018 Aug;57(3):235-243. 10.4306/jknpa.2018.57.3.235.

Psychosocial Intervention for Patients with Schizophrenia

Affiliations
  • 1Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea. swkim@chonnam.ac.kr
  • 2MindLink, Gwangju Bukgu Community Mental Health and Welfare Center, Gwangju, Korea.
  • 3Gwangju Mental Health and Welfare Commission, Gwangju, Korea.

Abstract

Treatment of schizophrenia has as its ultimate goals, the functional recovery of the patients and improvement of their quality of life. While antipsychotic medication is the fundamental method for treating schizophrenia, it has certain limitations in terms of treating the illness beyond its positive symptoms. Therefore, psychosocial intervention should be used in tandem with pharmacological methods in treating schizophrenia. The efficacy of several modes of psychosocial intervention for improving outcomes in schizophrenia is well attested. Approximately 10 modes of psychosocial intervention have been recommended based on existing evidence, including family intervention, cognitive behavioral therapy, supported employment, early intervention services, lifestyle intervention for physical health enhancement, treatment of comorbid substance abuse, assertive community treatment, cognitive remediation, social skills training, and peer support. Ideally, these interventions are offered to patients in combination with one another. Over the last decade, increased emphasis has been placed on early detection and intervention, with particular focus on long-term recovery. Early intervention with comprehensive psychosocial interventions should be enacted promptly from the initial detection of schizophrenia.

Keyword

Schizophrenia; Psychosocial; Early intervention; Rehabilitation; Community; Mental health center

MeSH Terms

Cognitive Therapy
Community Mental Health Services
Early Intervention (Education)
Employment, Supported
Humans
Life Style
Methods
Quality of Life
Rehabilitation
Schizophrenia*
Social Skills
Substance-Related Disorders

Cited by  4 articles

Factors Affecting Admission Type in Patients with Schizophrenia Spectrum
Young Joo Park, Min Soo Ko, Ka Eul Kim, Kyeng Hyeng Jho, Hee Jung Nam
J Korean Neuropsychiatr Assoc. 2019;58(3):238-244.    doi: 10.4306/jknpa.2019.58.3.238.

The Effectiveness on Prevention of Rehospitalization with Long-Term Psychosocial Interventions for Patients with Major Psychiatric Disorders
Jae Hoon Jeong, Min Jeong Kang, Min Young Kwon, Sang Min Lee, Kyu Young Lee
Korean J Schizophr Res. 2019;22(2):66-73.    doi: 10.16946/kjsr.2019.22.2.66.

Supporting Patients With Schizophrenia in the Era of COVID-19
Sung-Wan Kim
Korean J Schizophr Res. 2021;24(2):45-51.    doi: 10.16946/kjsr.2021.24.2.45.

Early Intervention Model for Mental Health in Korean Youth: Mindlink
Sung-Wan Kim, Jae-Kyeong Kim, Cheol Park, Honey Kim, Min Jhon, Ju-Wan Kim, Seunghyoung Ryu, Ju-Yeon Lee, Jae-Min Kim
Korean J Schizophr Res. 2022;25(1):1-9.    doi: 10.16946/kjsr.2022.25.1.1.


Reference

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3:e442.
Article
2. Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016; 50:410–472.
Article
3. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017; 4:295–301.
Article
4. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004; 161:1334–1349.
Article
5. Marder SR. Integrating pharmacological and psychosocial treatments for schizophrenia. Acta Psychiatr Scand Suppl. 2000; (407):87–90.
6. Jukić V, Savić A, Herceg M. Importance of the newer generations of antipsychotics in reducing schizophrenia hospitalization rates. Psychiatr Danub. 2013; 25:329–333.
7. Norman R, Lecomte T, Addington D, Anderson E. Canadian treatment guidelines on psychosocial treatment of schizophrenia in adults. Can J Psychiatry. 2017; 62:617–623.
Article
8. Addington D, Anderson E, Kelly M, Lesage A, Summerville C. Canadian practice guidelines for comprehensive community treatment for schizophrenia and schizophrenia spectrum disorders. Can J Psychiatry. 2017; 62:662–672.
Article
9. Baandrup L, Østrup Rasmussen J, Klokker L, Austin S, Bjørnshave T, Fuglsang Bliksted V, et al. Treatment of adult patients with schizophrenia and complex mental health needs - a national clinical guideline. Nord J Psychiatry. 2016; 70:231–240.
Article
10. National Collaborating Centre for Mental Health. Psychosis and schizophrenia in adults: the NICE guideline on treatment and management. National Clinical Guideline 178. London: National Institute for Health and Care Excellence;2014.
11. Scottish Intercollegiate Guidelines Ne.twork. Management of schizophrenia (SIGN Guideline No. 131). Edinburgh: SIGN;2013.
12. Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010; 36:48–70.
Article
13. Marom S, Munitz H, Jones PB, Weizman A, Hermesh H. Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years. Schizophr Bull. 2005; 31:751–758.
Article
14. Grácio J, Gonçalves-Pereira M, Leff J. Key elements of a family intervention for schizophrenia: a qualitative analysis of an RCT. Fam Process. 2018; 57:100–112.
Article
15. Addington J, Addington D, Abidi S, Raedler T, Remington G. Canadian treatment guidelines for individuals at clinical high risk of psychosis. Can J Psychiatry. 2017; 62:656–661.
Article
16. Brabban A, Tai S, Turkington D. Predictors of outcome in brief cognitive behavior therapy for schizophrenia. Schizophr Bull. 2009; 35:859–864.
Article
17. Kim SW, Jang JE, Lee JY, Lee GY, Yu HY, Park C, et al. Effects of group cognitive-behavioral therapy in young patients in the early stage of psychosis. Psychiatry Investig. 2017; 14:609–617.
Article
18. Mizrahi R. Social stress and psychosis risk: common neurochemical substrates? Neuropsychopharmacology. 2016; 41:666–674.
Article
19. Beauchamp MC, Lecomte T, Lecomte C, Leclerc C, Corbière M. Do personality traits matter when choosing a group therapy for early psychosis? Psychol Psychother. 2013; 86:19–32.
Article
20. Nelson B, Philips LJ, Bechdolf A, Francey SM. Cognitive Behavioural Case Management (CBCM) for the NEURAPRO-E study. version 1. Melbourne: Orygen Youth Health;2008.
21. Kim KR, Lee SY, Kang JI, Kim BR, Choi SH, Park JY, et al. Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis. Early Interv Psychiatry. 2011; 5:174–178.
Article
22. Chung YC, Yoon KS, Park TW, Yang JC, Oh KY. Group cognitive-behavioral therapy for early psychosis. Cognit Ther Res. 2013; 37:403–411.
Article
23. Lee GY, Yu HY, Jhon M, Yoon JS, Kim SW. Intensive cognitive behavioral case management for functional recovery of young patients with schizophrenia. Korean J Schizophr Res. 2016; 19:32–37.
Article
24. Kinoshita Y, Furukawa TA, Kinoshita K, Honyashiki M, Omori IM, Marshall M, et al. Supported employment for adults with severe mental illness. Cochrane Database Syst Rev. 2013; (9):CD008297.
Article
25. Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, et al. The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components. Psychiatr Serv. 2015; 66:680–690.
Article
26. McFarlane WR, Dushay RA, Deakins SM, Stastny P, Lukens EP, Toran J, et al. Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry. 2000; 70:203–214.
Article
27. Bond GR, Resnick SG, Drake RE, Xie H, McHugo GJ, Bebout RR. Does competitive employment improve nonvocational outcomes for people with severe mental illness? J Consult Clin Psychol. 2001; 69:489–501.
Article
28. Álvarez-Jiménez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Killackey E, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med. 2012; 42:595–606.
Article
29. Kim EJ, Lim SY, Lee HJ, Lee JY, Choi S, Kim SY, et al. Low dietary intake of n-3 fatty acids, niacin, folate, and vitamin C in Korean patients with schizophrenia and the development of dietary guidelines for schizophrenia. Nutr Res. 2017; 45:10–18.
Article
30. Roffman JL, Petruzzi LJ, Tanner AS, Brown HE, Eryilmaz H, Ho NF, et al. Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial. Mol Psychiatry. 2018; 23:316–322.
Article
31. Amminger GP, Schäfer MR, Schlögelhofer M, Klier CM, McGorry PD. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun. 2015; 6:7934.
Article
32. Kim SW, Jhon M, Kim JM, Smesny S, Rice S, Berk M, et al. Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 Ssudy. PLoS One. 2016; 11:e0151417.
33. Rimes RR, de Souza Moura AM, Lamego MK, de Sá Filho AS, Manochio J, Paes F, et al. Effects of exercise on physical and mental health, and cognitive and brain functions in schizophrenia: clinical and experimental evidence. CNS Neurol Disord Drug Targets. 2015; 14:1244–1254.
Article
34. McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry. 2002; 1:76–83.
35. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005; 162:1785–1804.
Article
36. Kane JM, Robinson DG, Schooler NR, Mueser KT, Penn DL, Rosenheck RA, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry. 2016; 173:362–372.
Article
37. Caton CL. The need for close monitoring of early psychosis and cooccurring substance misuse. Psychiatrist. 2011; 35:241–243.
Article
38. Barnes TR, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry. 2006; 188:237–242.
Article
39. Crockford D, Addington D. Canadian schizophrenia guidelines: schizophrenia and other psychotic disorders with coexisting substance use disorders. Can J Psychiatry. 2017; 62:624–634.
Article
40. Na E, Roh S. Treatment of tobacco use disorders in people with mental illness. J Korean Soc Res Nicotine Tob. 2015; 6:78–85.
Article
41. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev. 2011; (4):CD001089.
Article
42. Brewer WJ, Lambert TJ, Witt K, Dileo J, Duff C, Crlenjak C, et al. Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes. Lancet Psychiatry. 2015; 2:29–37.
Article
43. Morin L, Franck N. Rehabilitation interventions to promote recovery from schizophrenia: a systematic review. Front Psychiatry. 2017; 8:100.
Article
44. van Oosterhout B, Smit F, Krabbendam L, Castelein S, Staring AB, van der Gaag M. Metacognitive training for schizophrenia spectrum patients: a meta-analysis on outcome studies. Psychol Med. 2016; 46:47–57.
Article
45. Varga E, Endre S, Molnár D, Tényi T, Herold R. Efficacy of metacognitive training compared with a psychosocial rehabilitation program on social cognitive processing in schizophrenia. Eur Neuropsychopharmacol. 2017; 27:S959.
Article
46. Nestor P, Galletly C. The employment of consumers in mental health services: politically correct tokenism or genuinely useful? Australas Psychiatry. 2008; 16:344–347.
Article
47. Pitt V, Lowe D, Hill S, Prictor M, Hetrick SE, Ryan R, et al. Consumer-providers of care for adult clients of statutory mental health services. Cochrane Database Syst Rev. 2013; (3):CD004807.
Article
48. Kendall T, Whittington CJ, Kuipers E, Johnson S, Birchwood MJ, Marshall M, et al. NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations. Br J Psychiatry. 2016; 208:316–319.
Article
49. Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018; 5:31–40.
Article
50. Khoury B, Lecomte T, Gaudiano BA, Paquin K. Mindfulness interventions for psychosis: a meta-analysis. Schizophr Res. 2013; 150:176–184.
Article
51. Louise S, Fitzpatrick M, Strauss C, Rossell SL, Thomas N. Mindfulness- and acceptance-based interventions for psychosis: our current understanding and a meta-analysis. Schizophr Res. 2018; 192:57–63.
Article
52. Edwards J, Cocks J, Bott J. Preventive case management in first-episode psychosis. In : McGorry PD, Jackson HJ, editors. The recognition and management of early psychosis. A preventive approach. Cambridge: Cambridge University Press;1999.
53. Rickwood DJ, Telford NR, Parker AG, Tanti CJ, McGorry PD. Headspace - Australia's innovation in youth mental health: who are the clients and why are they presenting? Med J Aust. 2014; 200:108–111.
Article
54. Iyer S, Jordan G, MacDonald K, Joober R, Malla A. Early intervention for psychosis: a Canadian perspective. J Nerv Ment Dis. 2015; 203:356–364.
55. Birchwood M, Connor C, Lester H, Patterson P, Freemantle N, Marshall M, et al. Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services. Br J Psychiatry. 2013; 203:58–64.
Article
56. National Institute for Clinical Excellence. Implementing the early intervention in psychosis access and waiting time standard: Guidance. London: NHS England Publications;2016.
57. Zhang Z, Zhai J, Wei Q, Qi J, Guo X, Zhao J. Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study. BMC Psychiatry. 2014; 14:212.
Article
58. Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2018; 75:555–565.
Article
59. Kim SW, Lee GY, Yu HY, Jung EI, Lee JY, Kim SY, et al. Development and feasibility of smartphone application for cognitive behavioural case management of individuals with early psychosis. Early Interv Psychiatry. In press 2017.
60. Kim SW, Chung YC, Kang YS, Kim JK, Jang JE, Jhon M, et al. Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population. Psychiatry Investig. 2018; 15:111–117.
Article
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr